Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Matthew Edey"'
Autor:
Peter F Zipfel, Matthew Edey, Stefan Heinen, Mihály Józsi, Heiko Richter, Joachim Misselwitz, Bernd Hoppe, Danny Routledge, Lisa Strain, Anne E Hughes, Judith A Goodship, Christoph Licht, Timothy H J Goodship, Christine Skerka
Publikováno v:
PLoS Genetics, Vol 3, Iss 3, p e41 (2007)
Atypical hemolytic uremic syndrome (aHUS) is associated with defective complement regulation. Disease-associated mutations have been described in the genes encoding the complement regulators complement factor H, membrane cofactor protein, factor B, a
Externí odkaz:
https://doaj.org/article/5dbab60a997e4d30ae0bf040891b6ada
Autor:
David Philip Lowe, Matthew Edey, Habib Kashi, Daniel Zehnder, Nithya Krishnan, Rizwan Hamer, Klaus Chen, M. Hathaway, Robert Higgins, C. Imray, Clare Williams, Sunil Daga, Simon Fletcher, David Briggs, Lam Chin Tan, For T. Lam
Publikováno v:
Transplantation. 92:900-906
Background. Human leukocyte antigen (HLA) antibody-incompatible renal transplantation has been increasingly performed since 2000 but with few data on the medium-term outcomes. Methods. Between 2003 and 2011, 84 patients received renal transplants wit
Publikováno v:
Nephrology. 15:137-145
The incidence of hepatitis B virus (HBV) infection in dialysis populations has declined over recent decades, largely because of improvements in infection control and widespread implementation of HBV vaccination. Regardless, outbreaks of infection con
Publikováno v:
Molecular Immunology. 46:1405-1408
There is substantial evidence to suggest that complement activation plays a pivotal role in the pathogenesis of IgA nephropathy. Mesangial C3 deposition is seen in approximately 90% of patients and polymeric IgA has been shown to activate the alterna
Autor:
David J. Kavanagh, Martha Diaz-Torres, Frida C Bergstrom, Carol Inward, Judith A. Goodship, Matthew Edey, Nadeem E. Moghal, Bruno O. Villoutreix, Véronique Frémeaux-Bacchi, Lisa Strain, Timothy H.J. Goodship, Charles R.V. Tomson, AK Lampe, Mary McHugh, Anna M. Blom
Publikováno v:
Scopus-Elsevier
ResearcherID
ResearcherID
Atypical hemolytic uremic syndrome (aHUS) is a disorder characterized by hemolytic anemia, thrombocytopenia, and acute renal failure. Mutations, polymorphisms, and copy number variation in complement factors and inhibitors are associated with aHUS. I
Autor:
Johan B. Rosman, David W. Johnson, Stephen P. McDonald, Kathryn J. Wiggins, Fiona G. Brown, Carmel M. Hawley, Matthew Edey, Kym M. Bannister
Publikováno v:
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 25(4)
Background. Enterococcal peritonitis is a serious complication of peritoneal dialysis (PD), although reports of this condition in the literature are exceedingly limited.Methods. The frequency, predictors, treatment and clinical outcomes of enterococc
Autor:
Paul A. Mead, Stephen J. Perkins, N. Suren Kanagasundaram, Lisa Strain, Timothy H.J. Goodship, Rebecca E. Saunders, Matthew Edey
Publikováno v:
American journal of kidney diseases : the official journal of the National Kidney Foundation. 51(3)
Hemolytic uremic syndrome (HUS) takes 2 forms: diarrheal HUS and nondiarrheal HUS. As its name suggests, diarrheal HUS classically follows an enteric infection. The classic infective organism is the Escherichia coli O157 serotype, although other bact
Autor:
Judith A. Goodship, Matthew Edey, Stefan Heinen, Lisa Strain, Danny Routledge, Peter F. Zipfel, Mihály Józsi, Timothy H.J. Goodship, Anne E. Hughes, Heiko Richter, Christoph Licht, Bernd Hoppe, Christine Skerka, Joachim Misselwitz
Publikováno v:
PLoS Genetics
PLoS Genetics, Vol 3, Iss 3, p e41 (2007)
PLoS Genetics, Vol 3, Iss 3, p e41 (2007)
Atypical hemolytic uremic syndrome (aHUS) is associated with defective complement regulation. Disease-associated mutations have been described in the genes encoding the complement regulators complement factor H, membrane cofactor protein, factor B, a
Publikováno v:
New England Journal of Medicine. 353:846-847
To the Editor: The regression of Kaposi's sarcoma in renal-graft recipients after switching from treatment with cyclosporine and mycophenolate mofetil to sirolimus, as reported by Stallone et al. (March 31 issue),1 is remarkable and confirms earlier
Autor:
Matthew Edey
Publikováno v:
New England Journal of Medicine. 361:1511-1511